8 Patents
- US126066362026Treatment of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US125595622026Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites - US123503342025Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
The Trustees Of The University Of Pennsylvania
0 cites - US122342742025Use of the CD2 Signaling Domain in Second-generation Chimeric Antigen Receptors
The Trustees Of The University Of Pennsylvania
0 cites - US119588922024Use of Icos-based Cars to Enhance Antitumor Activity and Car Persistence
The Trustees Of The University Of Pennsylvania
0 cites - US118651672024Treatment of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
University Of Pittsburgh—of The Commonwealth System Of Higher Education
0 cites - US117186852023Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
The Wistar Institute Of Anatomy And Biology
0 cites - US115977542023Use of the CD2 Signaling Domain in Second-generation Chimeric Antigen Receptors
The Trustees Of The University Of Pennsylvania
0 cites